Mineralys Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2022 Dec2023 Dec2024
Operating Activities
Share-based Compensation 0.46M5.06M11.34M
Cash from Operations -29.22M-81.17M-166.31M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.65M6.87M9.40M
Depreciation & Amortization (CF) 0.04M
Change in Working Capital
Change in Accured Expenses 3.01M2.42M4.16M
Other Working Capital Changes 2.24M9.53M-4.93M
Investing Activities
Capital Expenditures 0.10M
Change in Acquisitions & Divestments 50.00M187.50M488.50M
Cash from Investing Activities -21.76M-160.47M114.96M
Financing Activities
Other financing activities 0.43M
Cash from Financing Activities 128.02M203.25M116.14M
Additional items
Change in Cash 77.04M-38.40M64.79M
Free Cash Flow -29.22M-81.17M-166.41M
Net Cash Flow 77.04M-38.40M64.79M